Allogene Therapeutics, created in 2017 (United States), from 2214 competing brands. Allogene Therapeutics is a brand of ALLOGENE THERAPEUTICS INC, listed on the stock exchange of New York. Allogene Therapeutics is part of the Biotechnology activity sector.
Investment simulator :
Portfolio valuation
ALLOGENE THERAPEUTICS INC
(Allogene Therapeutics)
over 5 years*
USD 0.27